Millennium Management’s Ginkgo Bioworks DNA Stock Holding History

Millennium Management’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,250	Closed	-$1.54M	–	6173
2023 Q3	$1.54M	Buy	+21,250	New	+$1.7M	﹤0.01%	3815
2023 Q2	–	Sell	-12,500	Closed	-$665K	–	6199
2023 Q1	$665K	Hold	12,500	–	–	﹤0.01%	4422
2022 Q4	$845K	Sell	12,500 -10,500	-46%	-$966K	﹤0.01%	4327
2022 Q3	$2.87M	Buy	+23,000	New	+$2.74M	﹤0.01%	3434
2022 Q2	–	Sell	-10,000	Closed	-$1.61M	–	7071
2022 Q1	$1.61M	Buy	10,000 +2,500	+33%	+$487K	﹤0.01%	4073
2021 Q4	$2.49M	Buy	+7,500	New	+$3.56M	﹤0.01%	3563

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's DNA Position: Q1 2026 in Review

Millennium Management increased its Ginkgo Bioworks (DNA) stake by 898% in Q1 2026, buying an estimated $3.65M and bringing the position to 487,957 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3466.

Millennium Management first reported a position in DNA in Q3 2021 and has held it in 17 quarters since. The position peaked at $17.5M in Q3 2021. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

Millennium Management held 487,957 shares of Ginkgo Bioworks worth $2.99M as of Q1 2026.
Millennium Management bought 439,056 Ginkgo Bioworks shares in Q1 2026, an estimated $3.65M.
Ginkgo Bioworks made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3466 holding.
Millennium Management first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 17 quarters since.
Millennium Management's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.